SlideShare ist ein Scribd-Unternehmen logo
1 von 30
Downloaden Sie, um offline zu lesen
Supervised Injecting Facilities
‘The case’
University College Cork
Wednesday 26th September 2012
Who am I
 Tim Bingham
Co ordinate The Irish Needle Exchange Forum
National harm reduction forum

22 years working in the field
Independent researcher and trainer
What is harm reduction
Harm reduction complements approaches that
seek to prevent or reduce the overall level of drug
Consumption. Harm reduction can often be
arranged in a hierarchy with the more feasible
options at one end (e.g. measures to keep people
healthy) and less feasible but desirable options at
the other end.
Abstinence can be considered difficult to achieve
but desirable option for harm reduction in such a
hierarchy.
History of Harm Reduction
Up until the 1980s, drug services around the world
were mainly directed towards ‘curing’ addictions.

The term ‘harm reduction’ became prominent in
the mid-1980s as a response to newly discovered
HIV epidemics amongst people who inject drugs in
some cities

Liverpool was one of the first to open needle
exchanges, and attracted hundreds of visitors each
year who wanted to learn about the 'Mersey Harm
Reduction Model'. 1st International Conference on
the Reduction of Drug Related Harm, held in
Liverpool, England in 1990.
Harm Reduction in Ireland
Commissioned by the NACD in response to
Action 100 of the National Drug Strategy, this
Review was prepared by a team from Dublin
City University (DCU) and the NACD is
grateful to them for their work.
It is clear from this Review that Irish harm
reduction services need to be more flexible,
be available in all health boards and in areas
of greatest need.
Alternative approaches should be considered
to support the expansion of harm reduction
services such as Community Pharmacy
Needle Exchange
Harm reduction services should have the
flexibility to cater for the provision and/or
exchange of a range of drug use
paraphernalia so as to reduce the risk of
contracting drug related infectious diseases
and other harm.

We know that Hepatitis C Virus, in particular,
is a very resilient organism and this has
implications for sharing any piece of drug
taking equipment. As part of that greater
flexibility, there is a need for enhanced
training for service providers
Supervised injecting facilities
What are they ?
Drug Consumption Rooms (DCR’s) are professionally
supervised healthcare facilities Hedrich (2010).
Providing safer and more hygienic environment for
drug users Stover (2000) Drug Consumption Rooms
are defined as ‘legally sanctioned low threshold
facilities which allow the hygienic consumption of
pre-obtained drugs under professional supervision
in a non-judgemental environment’
Supervised injecting facilities what
are they ?
The effect of a drug is determined by its
pharmacology, its administration, the person taking
it and the context its taken in, drug, set and setting
(Zinberg) 1984 these factors affect the risk and
harm of drug use.
Defined as ‘protected places for the hygienic
consumption of preobtained drugs in a nonjudgemental environment and under the
supervision of trained staff’ Akzept, (2000)
Supervised injecting facilities what
are they ?
Insite - Vancouver

Sydney - MISC
European Picture
DCRs varies across the region, with
nationwide coverage in Switzerland and the
Netherlands, regional coverage in Germany
and Spain, and DCRs in the
capital cities only in Norway and Luxembourg. I
In total there are 85 DCRs across 56 cities in
these six countries, the majority of them
integrated into more general health and social
service provision networks.
The Global State of Harm Reduction 2012
Towards an integrated response
UK Picture
The legal issue
Article 4 of the 1961 Convention, which obliges those states
which have signed up to the convention (which Ireland has)
states that the ‘trade in’, use and possession of drugs is limited
exclusively to medical and academic purposes.
In Ireland, the Misuse of Drugs Act 1977 and 1984 ensures
Irelands compliance under International Law.
HOWEVER The legal issue
However the UNDCP Legal Affairs Section, (2002) say ‘It might
be claimed that this approach SIFs is incompatible with the
obligation to prevent the abuse of drugs…
It should not be forgotten, however, that the same provisions
create an obligations to treat, rehabilitate and reintegrate
drug addicts, whose implementation depends largely on the
interpretation by the Parties of the terms in question.
If, for example, the purpose of treatment is not only to cure
a pathology, but also to reduce the suffering associated with
it (like in severe pain management), then reducing IV drug
abusers exposure to pathogen agents such as HIV and
hepatitis should be considered as ‘treatment.’
HOWEVER The legal issue
Needless to say that, to be consistent with a
comprehensive demand-reduction strategy, any
such approach would also require counselling
and other health and welfare services, aimed at
promoting healthier life-styles and, eventually,
abstinence. FLEXIBILITY OF TREATY PROVISIONS AS REGARDS HARM REDUCTION
APPROACHES (Decision 74/10)
Yes …. We can do it
David Cameron who in 2002 voted in
favour of supervised injecting rooms
being launched in the UK.
Evaluation
 40 % of clients referred on by MSIC
to addiction treatment services had
never previously accessed treatment
for their drug addiction.
 Regular interaction with health
services over time can increase the
likelihood that a client will seek help
for their drug use.
 The MSIC data show that while all
clients are offered referral and
assistance, the proportion of clients
who accept a referral increases
dramatically the more visits they
have made
The majority of surveyed clients agreed with
the statements:
‘Since coming here, the MSIC has helped me’:
‘get in contact with other service (i.e. use the
telephone at the MSIC to call another
service’ (82%)
‘get help with other issues such as accessing
services such as housing and legal
services’ (73%)
.
‘Have you accessed other health or support
services since you have come to the
MSIC?’
The majority of clients reported that they had
accessed other non-AOD services
since they started using the MSIC.
The evidence
The evidence
 People using Insite are more likely to enter withdrawal
management (detox) programs than injection drug users who do
not use the facility.
 The likelihood of entering detox goes up even further if the person
uses Insite weekly, and first speaks with an addiction counsellor.
 The research shows that patterns of drug use in the community did
not worsen as a result of Insite, and crimes related to drug use
have not increased.
 A reduction of the number of people openly injecting on the
streets and the amount of injection-related litter that was left
behind.
The evidence






FACT Medical Supervised Injecting Centres (MISC) saves lives
FACT Does not attract drug users to the area
FACT Provides a gateway to drug treatment and counselling
FACT Local residents supports MSIC
FACT Reduces problems with public injecting and discarded
needles and/or syringes
 FACT Decreasing drug overdose deaths
 FACT Reducing the spread of diseases such as HIV and
Hepatitis C
This is not new
2002 Merchants Quay Ireland conference on SIF/MISC
2003 – Minister for Justice – Michael McDowell
“ Controlled injecting rooms might be an idea, because I know it has been
suggested…. The question you have to ask yourself is, is it good enough
simply to give needle exchanges, to exchange needles, new needles for
people to stop the spread of AIDS without at the same time giving some
facilities? What do you expect people who pick up needles to do? “
“I would be very, very loath to have official injecting rooms…I don’t think
that’s a good idea, no. It’s an indictable offence to have heroin………..I’m not
going to go down the road of providing places for people to shoot up
heroin” (RTE 2003)
So why have a MISC in Ireland
So today where are we today?

2012
The issue of substance-related anti-social
behaviour is primarily a public health
issue and any sustainable long term
solution can only be delivered in that
context
The establishment of medically
supervised injecting centres
So today where are we ?
Support the establishment of a
pilot project of a Medically
Supervised Injecting Centre to
enable the gathering of evidence
on the effectiveness on this
initiative to reduce harm for drug
users engaged in risky behaviour
(HSE)
And then ……
DÁIL QUESTIONS addressed to the Minister of State at the Department of
Health (Ms. Shortall) 18/09/2012
It is not my intention to introduce supervised injection sites for heroin users.
Rather my focus is on
ensuring that there is an increased emphasis on providing the opportunities
for people to move on from illicit drug use, through drug treatment and
rehabilitation, to a drug-free life where that is achievable.

A 2012 report from the European Monitoring Centre for Drugs and Drug
Addiction (EMCDDA) indicates that heroin-assisted treatment is made
available only in a small number of European countries. While the report
found some evidence that this treatment can be effective for a small minority
of entrenched opioid users, the EMCDDA made clear that it was reporting
only, rather than advocating the provision of such services.
So the evidence ……
Proving safer injecting facilities should be viewed as a
treatment option to provide the opportunities for people
to move on from illicit drug use, through drug treatment
and rehabilitation, to a drug-free life where that is
achievable.
All the pieces to the jig saw fit ……
Recommended books ……
Thanks for listening
Tim Bingham
Email tim@inef.ie
Website www.inef.ie

Weitere ähnliche Inhalte

Was ist angesagt?

'It's there own fault for taking drugs' Professorial Lecture Glyndwr Universi...
'It's there own fault for taking drugs' Professorial Lecture Glyndwr Universi...'It's there own fault for taking drugs' Professorial Lecture Glyndwr Universi...
'It's there own fault for taking drugs' Professorial Lecture Glyndwr Universi...Julian Buchanan
 
Cannabis andharmreduction
Cannabis andharmreductionCannabis andharmreduction
Cannabis andharmreductionGonzilla Sach
 
Racial and Socioeconomic Disparities in Substance Abuse Treatment
Racial and Socioeconomic Disparities in Substance Abuse TreatmentRacial and Socioeconomic Disparities in Substance Abuse Treatment
Racial and Socioeconomic Disparities in Substance Abuse TreatmentAlexandraPerkins5
 
New Zealand Drug Courts: Driven by ideology or evidence?
New Zealand Drug Courts: Driven by ideology or evidence?New Zealand Drug Courts: Driven by ideology or evidence?
New Zealand Drug Courts: Driven by ideology or evidence?Julian Buchanan
 
Opioids and harm reduction
Opioids and harm reductionOpioids and harm reduction
Opioids and harm reductionJustinJordan15
 
Risk reduction final-rev
Risk reduction final-revRisk reduction final-rev
Risk reduction final-revOPUNITE
 
81-240-1 Chapter 06
81-240-1 Chapter 0681-240-1 Chapter 06
81-240-1 Chapter 06mpalaro
 
First model of one stop service for drug users in drug dependent centers in s...
First model of one stop service for drug users in drug dependent centers in s...First model of one stop service for drug users in drug dependent centers in s...
First model of one stop service for drug users in drug dependent centers in s...Alexander Decker
 
Dana harm reduction 2
Dana harm reduction 2Dana harm reduction 2
Dana harm reduction 2donone
 
Jacqui Brown - Harm Reduction 101
Jacqui Brown - Harm Reduction 101Jacqui Brown - Harm Reduction 101
Jacqui Brown - Harm Reduction 101Nerd Nite Siem Reap
 
S_brief_I_referral_T-i
S_brief_I_referral_T-iS_brief_I_referral_T-i
S_brief_I_referral_T-imedicaldump
 
What works in prevention: education and awareness
What works in prevention: education and awarenessWhat works in prevention: education and awareness
What works in prevention: education and awarenessWorkingwithsubstanceabuse
 
Mmt aproach to young DU-s
Mmt aproach to young DU-sMmt aproach to young DU-s
Mmt aproach to young DU-syouthrise
 
Reclaiming Futures: Programa Tratamiento Rehabilitación Consumo de Drogas EE.UU.
Reclaiming Futures: Programa Tratamiento Rehabilitación Consumo de Drogas EE.UU.Reclaiming Futures: Programa Tratamiento Rehabilitación Consumo de Drogas EE.UU.
Reclaiming Futures: Programa Tratamiento Rehabilitación Consumo de Drogas EE.UU.Francisco J. Estrada Vásquez
 

Was ist angesagt? (20)

'It's there own fault for taking drugs' Professorial Lecture Glyndwr Universi...
'It's there own fault for taking drugs' Professorial Lecture Glyndwr Universi...'It's there own fault for taking drugs' Professorial Lecture Glyndwr Universi...
'It's there own fault for taking drugs' Professorial Lecture Glyndwr Universi...
 
Cannabis andharmreduction
Cannabis andharmreductionCannabis andharmreduction
Cannabis andharmreduction
 
Racial and Socioeconomic Disparities in Substance Abuse Treatment
Racial and Socioeconomic Disparities in Substance Abuse TreatmentRacial and Socioeconomic Disparities in Substance Abuse Treatment
Racial and Socioeconomic Disparities in Substance Abuse Treatment
 
New Zealand Drug Courts: Driven by ideology or evidence?
New Zealand Drug Courts: Driven by ideology or evidence?New Zealand Drug Courts: Driven by ideology or evidence?
New Zealand Drug Courts: Driven by ideology or evidence?
 
Drug Use: Stigma, Stereotypes and Harm Reduction
Drug Use: Stigma, Stereotypes and Harm ReductionDrug Use: Stigma, Stereotypes and Harm Reduction
Drug Use: Stigma, Stereotypes and Harm Reduction
 
Opioids and harm reduction
Opioids and harm reductionOpioids and harm reduction
Opioids and harm reduction
 
Conference Slides
Conference SlidesConference Slides
Conference Slides
 
Risk reduction final-rev
Risk reduction final-revRisk reduction final-rev
Risk reduction final-rev
 
81-240-1 Chapter 06
81-240-1 Chapter 0681-240-1 Chapter 06
81-240-1 Chapter 06
 
First model of one stop service for drug users in drug dependent centers in s...
First model of one stop service for drug users in drug dependent centers in s...First model of one stop service for drug users in drug dependent centers in s...
First model of one stop service for drug users in drug dependent centers in s...
 
Dana harm reduction 2
Dana harm reduction 2Dana harm reduction 2
Dana harm reduction 2
 
Jacqui Brown - Harm Reduction 101
Jacqui Brown - Harm Reduction 101Jacqui Brown - Harm Reduction 101
Jacqui Brown - Harm Reduction 101
 
S_brief_I_referral_T-i
S_brief_I_referral_T-iS_brief_I_referral_T-i
S_brief_I_referral_T-i
 
Opioid Awareness
Opioid AwarenessOpioid Awareness
Opioid Awareness
 
What works in prevention: education and awareness
What works in prevention: education and awarenessWhat works in prevention: education and awareness
What works in prevention: education and awareness
 
Mmt aproach to young DU-s
Mmt aproach to young DU-sMmt aproach to young DU-s
Mmt aproach to young DU-s
 
Drug Courts Work!
Drug Courts Work!Drug Courts Work!
Drug Courts Work!
 
Smoking Cessation Interventions: A Selected Review of the Research Literature.
Smoking Cessation Interventions: A Selected Review of the Research Literature.Smoking Cessation Interventions: A Selected Review of the Research Literature.
Smoking Cessation Interventions: A Selected Review of the Research Literature.
 
Mental Health Advocacy and Research
Mental Health Advocacy and ResearchMental Health Advocacy and Research
Mental Health Advocacy and Research
 
Reclaiming Futures: Programa Tratamiento Rehabilitación Consumo de Drogas EE.UU.
Reclaiming Futures: Programa Tratamiento Rehabilitación Consumo de Drogas EE.UU.Reclaiming Futures: Programa Tratamiento Rehabilitación Consumo de Drogas EE.UU.
Reclaiming Futures: Programa Tratamiento Rehabilitación Consumo de Drogas EE.UU.
 

Ähnlich wie Supervised Injecting Facilities ‘The case’

WHO Guideline of Medicine Policy.pdf
WHO Guideline of Medicine Policy.pdfWHO Guideline of Medicine Policy.pdf
WHO Guideline of Medicine Policy.pdfPurbanchal University
 
POISON CONTROL CENTRE
POISON CONTROL CENTREPOISON CONTROL CENTRE
POISON CONTROL CENTREMUSHTAQ AHMED
 
Personalised healthcare short guide (for web)
Personalised healthcare short guide (for web)Personalised healthcare short guide (for web)
Personalised healthcare short guide (for web)benj_2
 
Health-care interventions to promote and assist tobacco cessation: a review o...
Health-care interventions to promote and assist tobacco cessation: a review o...Health-care interventions to promote and assist tobacco cessation: a review o...
Health-care interventions to promote and assist tobacco cessation: a review o...Georgi Daskalov
 
Tobacco dependence treatment makes no sense
Tobacco dependence treatment makes no senseTobacco dependence treatment makes no sense
Tobacco dependence treatment makes no senseGeorgi Daskalov
 
Core harm reduction_infonote_en
Core harm reduction_infonote_enCore harm reduction_infonote_en
Core harm reduction_infonote_enclac.cab
 
Harm reduction for people who use drugs
Harm reduction for people who use drugsHarm reduction for people who use drugs
Harm reduction for people who use drugsclac.cab
 
PartialCapstoneforLinkedIn
PartialCapstoneforLinkedInPartialCapstoneforLinkedIn
PartialCapstoneforLinkedInJK Costello
 
Mr. G. Charanjit Sharma_Harm reduction for PWID and counseling needs_14-08-20...
Mr. G. Charanjit Sharma_Harm reduction for PWID and counseling needs_14-08-20...Mr. G. Charanjit Sharma_Harm reduction for PWID and counseling needs_14-08-20...
Mr. G. Charanjit Sharma_Harm reduction for PWID and counseling needs_14-08-20...AmitMohite28
 
Final how brief can we go a short study of professional health advice to the ...
Final how brief can we go a short study of professional health advice to the ...Final how brief can we go a short study of professional health advice to the ...
Final how brief can we go a short study of professional health advice to the ...Centre for Public Health
 
Ilaria passarani - Selling Sickness 2010
Ilaria passarani - Selling Sickness 2010Ilaria passarani - Selling Sickness 2010
Ilaria passarani - Selling Sickness 2010Gezonde scepsis
 
Cuci tangan standart who
Cuci tangan standart whoCuci tangan standart who
Cuci tangan standart whoaku kamu
 
Health_2014091211101932 (4)
Health_2014091211101932 (4)Health_2014091211101932 (4)
Health_2014091211101932 (4)Farhang Dehzad
 
Healthy Savings. Medical Technology and the Economic Burden of Disease
Healthy Savings. Medical Technology and the Economic Burden of DiseaseHealthy Savings. Medical Technology and the Economic Burden of Disease
Healthy Savings. Medical Technology and the Economic Burden of DiseaseRevital (Tali) Hirsch
 

Ähnlich wie Supervised Injecting Facilities ‘The case’ (20)

WHO Guideline of Medicine Policy.pdf
WHO Guideline of Medicine Policy.pdfWHO Guideline of Medicine Policy.pdf
WHO Guideline of Medicine Policy.pdf
 
Sas overview logo
Sas overview logoSas overview logo
Sas overview logo
 
POISON CONTROL CENTRE
POISON CONTROL CENTREPOISON CONTROL CENTRE
POISON CONTROL CENTRE
 
Personalised healthcare short guide (for web)
Personalised healthcare short guide (for web)Personalised healthcare short guide (for web)
Personalised healthcare short guide (for web)
 
Health-care interventions to promote and assist tobacco cessation: a review o...
Health-care interventions to promote and assist tobacco cessation: a review o...Health-care interventions to promote and assist tobacco cessation: a review o...
Health-care interventions to promote and assist tobacco cessation: a review o...
 
Tobacco control
Tobacco controlTobacco control
Tobacco control
 
Tobacco dependence treatment makes no sense
Tobacco dependence treatment makes no senseTobacco dependence treatment makes no sense
Tobacco dependence treatment makes no sense
 
Core harm reduction_infonote_en
Core harm reduction_infonote_enCore harm reduction_infonote_en
Core harm reduction_infonote_en
 
Harm reduction for people who use drugs
Harm reduction for people who use drugsHarm reduction for people who use drugs
Harm reduction for people who use drugs
 
PartialCapstoneforLinkedIn
PartialCapstoneforLinkedInPartialCapstoneforLinkedIn
PartialCapstoneforLinkedIn
 
Mr. G. Charanjit Sharma_Harm reduction for PWID and counseling needs_14-08-20...
Mr. G. Charanjit Sharma_Harm reduction for PWID and counseling needs_14-08-20...Mr. G. Charanjit Sharma_Harm reduction for PWID and counseling needs_14-08-20...
Mr. G. Charanjit Sharma_Harm reduction for PWID and counseling needs_14-08-20...
 
Final how brief can we go a short study of professional health advice to the ...
Final how brief can we go a short study of professional health advice to the ...Final how brief can we go a short study of professional health advice to the ...
Final how brief can we go a short study of professional health advice to the ...
 
Ilaria passarani - Selling Sickness 2010
Ilaria passarani - Selling Sickness 2010Ilaria passarani - Selling Sickness 2010
Ilaria passarani - Selling Sickness 2010
 
Cuci tangan standart who
Cuci tangan standart whoCuci tangan standart who
Cuci tangan standart who
 
ABPI white paper
ABPI white paperABPI white paper
ABPI white paper
 
Wc to h_programme_06b
Wc to h_programme_06bWc to h_programme_06b
Wc to h_programme_06b
 
CIOMS (1).pptx
CIOMS (1).pptxCIOMS (1).pptx
CIOMS (1).pptx
 
ITC_Mauritius
ITC_MauritiusITC_Mauritius
ITC_Mauritius
 
Health_2014091211101932 (4)
Health_2014091211101932 (4)Health_2014091211101932 (4)
Health_2014091211101932 (4)
 
Healthy Savings. Medical Technology and the Economic Burden of Disease
Healthy Savings. Medical Technology and the Economic Burden of DiseaseHealthy Savings. Medical Technology and the Economic Burden of Disease
Healthy Savings. Medical Technology and the Economic Burden of Disease
 

Mehr von Tim Bingham

Drug trends, responses and unintended consequences in Ireland
Drug trends, responses and unintended consequences in IrelandDrug trends, responses and unintended consequences in Ireland
Drug trends, responses and unintended consequences in IrelandTim Bingham
 
Drugs & tthe Dark Net
Drugs & tthe Dark NetDrugs & tthe Dark Net
Drugs & tthe Dark NetTim Bingham
 
Online drug markets and novel psychoactive drugs
Online drug markets and novel psychoactive drugs Online drug markets and novel psychoactive drugs
Online drug markets and novel psychoactive drugs Tim Bingham
 
Motivational Interviewing
Motivational Interviewing Motivational Interviewing
Motivational Interviewing Tim Bingham
 
Making Research Come Alive - University Limerick
Making Research Come Alive - University Limerick Making Research Come Alive - University Limerick
Making Research Come Alive - University Limerick Tim Bingham
 
Solution Focused Therapy
Solution Focused TherapySolution Focused Therapy
Solution Focused TherapyTim Bingham
 
Cognitive Behavioural & Relapse Prevention Strategies - University Limerick
Cognitive Behavioural & Relapse Prevention Strategies - University LimerickCognitive Behavioural & Relapse Prevention Strategies - University Limerick
Cognitive Behavioural & Relapse Prevention Strategies - University LimerickTim Bingham
 
Silk road presentation International Conference on Novel Psychoactive Substances
Silk road presentation International Conference on Novel Psychoactive SubstancesSilk road presentation International Conference on Novel Psychoactive Substances
Silk road presentation International Conference on Novel Psychoactive SubstancesTim Bingham
 

Mehr von Tim Bingham (8)

Drug trends, responses and unintended consequences in Ireland
Drug trends, responses and unintended consequences in IrelandDrug trends, responses and unintended consequences in Ireland
Drug trends, responses and unintended consequences in Ireland
 
Drugs & tthe Dark Net
Drugs & tthe Dark NetDrugs & tthe Dark Net
Drugs & tthe Dark Net
 
Online drug markets and novel psychoactive drugs
Online drug markets and novel psychoactive drugs Online drug markets and novel psychoactive drugs
Online drug markets and novel psychoactive drugs
 
Motivational Interviewing
Motivational Interviewing Motivational Interviewing
Motivational Interviewing
 
Making Research Come Alive - University Limerick
Making Research Come Alive - University Limerick Making Research Come Alive - University Limerick
Making Research Come Alive - University Limerick
 
Solution Focused Therapy
Solution Focused TherapySolution Focused Therapy
Solution Focused Therapy
 
Cognitive Behavioural & Relapse Prevention Strategies - University Limerick
Cognitive Behavioural & Relapse Prevention Strategies - University LimerickCognitive Behavioural & Relapse Prevention Strategies - University Limerick
Cognitive Behavioural & Relapse Prevention Strategies - University Limerick
 
Silk road presentation International Conference on Novel Psychoactive Substances
Silk road presentation International Conference on Novel Psychoactive SubstancesSilk road presentation International Conference on Novel Psychoactive Substances
Silk road presentation International Conference on Novel Psychoactive Substances
 

Kürzlich hochgeladen

COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
LESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingLESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingSakthi Kathiravan
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Monoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technologyMonoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technologyHasnat Tariq
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 

Kürzlich hochgeladen (20)

COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
LESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingLESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursing
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Monoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technologyMonoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technology
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 

Supervised Injecting Facilities ‘The case’

  • 1. Supervised Injecting Facilities ‘The case’ University College Cork Wednesday 26th September 2012
  • 2. Who am I  Tim Bingham Co ordinate The Irish Needle Exchange Forum National harm reduction forum 22 years working in the field Independent researcher and trainer
  • 3. What is harm reduction Harm reduction complements approaches that seek to prevent or reduce the overall level of drug Consumption. Harm reduction can often be arranged in a hierarchy with the more feasible options at one end (e.g. measures to keep people healthy) and less feasible but desirable options at the other end. Abstinence can be considered difficult to achieve but desirable option for harm reduction in such a hierarchy.
  • 4. History of Harm Reduction Up until the 1980s, drug services around the world were mainly directed towards ‘curing’ addictions. The term ‘harm reduction’ became prominent in the mid-1980s as a response to newly discovered HIV epidemics amongst people who inject drugs in some cities Liverpool was one of the first to open needle exchanges, and attracted hundreds of visitors each year who wanted to learn about the 'Mersey Harm Reduction Model'. 1st International Conference on the Reduction of Drug Related Harm, held in Liverpool, England in 1990.
  • 5. Harm Reduction in Ireland Commissioned by the NACD in response to Action 100 of the National Drug Strategy, this Review was prepared by a team from Dublin City University (DCU) and the NACD is grateful to them for their work. It is clear from this Review that Irish harm reduction services need to be more flexible, be available in all health boards and in areas of greatest need.
  • 6. Alternative approaches should be considered to support the expansion of harm reduction services such as Community Pharmacy Needle Exchange Harm reduction services should have the flexibility to cater for the provision and/or exchange of a range of drug use paraphernalia so as to reduce the risk of contracting drug related infectious diseases and other harm. We know that Hepatitis C Virus, in particular, is a very resilient organism and this has implications for sharing any piece of drug taking equipment. As part of that greater flexibility, there is a need for enhanced training for service providers
  • 7. Supervised injecting facilities What are they ? Drug Consumption Rooms (DCR’s) are professionally supervised healthcare facilities Hedrich (2010). Providing safer and more hygienic environment for drug users Stover (2000) Drug Consumption Rooms are defined as ‘legally sanctioned low threshold facilities which allow the hygienic consumption of pre-obtained drugs under professional supervision in a non-judgemental environment’
  • 8. Supervised injecting facilities what are they ? The effect of a drug is determined by its pharmacology, its administration, the person taking it and the context its taken in, drug, set and setting (Zinberg) 1984 these factors affect the risk and harm of drug use. Defined as ‘protected places for the hygienic consumption of preobtained drugs in a nonjudgemental environment and under the supervision of trained staff’ Akzept, (2000)
  • 9. Supervised injecting facilities what are they ? Insite - Vancouver Sydney - MISC
  • 10. European Picture DCRs varies across the region, with nationwide coverage in Switzerland and the Netherlands, regional coverage in Germany and Spain, and DCRs in the capital cities only in Norway and Luxembourg. I In total there are 85 DCRs across 56 cities in these six countries, the majority of them integrated into more general health and social service provision networks. The Global State of Harm Reduction 2012 Towards an integrated response
  • 12. The legal issue Article 4 of the 1961 Convention, which obliges those states which have signed up to the convention (which Ireland has) states that the ‘trade in’, use and possession of drugs is limited exclusively to medical and academic purposes. In Ireland, the Misuse of Drugs Act 1977 and 1984 ensures Irelands compliance under International Law.
  • 13. HOWEVER The legal issue However the UNDCP Legal Affairs Section, (2002) say ‘It might be claimed that this approach SIFs is incompatible with the obligation to prevent the abuse of drugs… It should not be forgotten, however, that the same provisions create an obligations to treat, rehabilitate and reintegrate drug addicts, whose implementation depends largely on the interpretation by the Parties of the terms in question. If, for example, the purpose of treatment is not only to cure a pathology, but also to reduce the suffering associated with it (like in severe pain management), then reducing IV drug abusers exposure to pathogen agents such as HIV and hepatitis should be considered as ‘treatment.’
  • 14. HOWEVER The legal issue Needless to say that, to be consistent with a comprehensive demand-reduction strategy, any such approach would also require counselling and other health and welfare services, aimed at promoting healthier life-styles and, eventually, abstinence. FLEXIBILITY OF TREATY PROVISIONS AS REGARDS HARM REDUCTION APPROACHES (Decision 74/10)
  • 15. Yes …. We can do it David Cameron who in 2002 voted in favour of supervised injecting rooms being launched in the UK.
  • 16. Evaluation  40 % of clients referred on by MSIC to addiction treatment services had never previously accessed treatment for their drug addiction.  Regular interaction with health services over time can increase the likelihood that a client will seek help for their drug use.  The MSIC data show that while all clients are offered referral and assistance, the proportion of clients who accept a referral increases dramatically the more visits they have made
  • 17. The majority of surveyed clients agreed with the statements: ‘Since coming here, the MSIC has helped me’: ‘get in contact with other service (i.e. use the telephone at the MSIC to call another service’ (82%) ‘get help with other issues such as accessing services such as housing and legal services’ (73%) . ‘Have you accessed other health or support services since you have come to the MSIC?’ The majority of clients reported that they had accessed other non-AOD services since they started using the MSIC.
  • 19. The evidence  People using Insite are more likely to enter withdrawal management (detox) programs than injection drug users who do not use the facility.  The likelihood of entering detox goes up even further if the person uses Insite weekly, and first speaks with an addiction counsellor.  The research shows that patterns of drug use in the community did not worsen as a result of Insite, and crimes related to drug use have not increased.  A reduction of the number of people openly injecting on the streets and the amount of injection-related litter that was left behind.
  • 20. The evidence      FACT Medical Supervised Injecting Centres (MISC) saves lives FACT Does not attract drug users to the area FACT Provides a gateway to drug treatment and counselling FACT Local residents supports MSIC FACT Reduces problems with public injecting and discarded needles and/or syringes  FACT Decreasing drug overdose deaths  FACT Reducing the spread of diseases such as HIV and Hepatitis C
  • 21. This is not new 2002 Merchants Quay Ireland conference on SIF/MISC 2003 – Minister for Justice – Michael McDowell “ Controlled injecting rooms might be an idea, because I know it has been suggested…. The question you have to ask yourself is, is it good enough simply to give needle exchanges, to exchange needles, new needles for people to stop the spread of AIDS without at the same time giving some facilities? What do you expect people who pick up needles to do? “ “I would be very, very loath to have official injecting rooms…I don’t think that’s a good idea, no. It’s an indictable offence to have heroin………..I’m not going to go down the road of providing places for people to shoot up heroin” (RTE 2003)
  • 22.
  • 23. So why have a MISC in Ireland
  • 24. So today where are we today? 2012 The issue of substance-related anti-social behaviour is primarily a public health issue and any sustainable long term solution can only be delivered in that context The establishment of medically supervised injecting centres
  • 25. So today where are we ? Support the establishment of a pilot project of a Medically Supervised Injecting Centre to enable the gathering of evidence on the effectiveness on this initiative to reduce harm for drug users engaged in risky behaviour (HSE)
  • 26. And then …… DÁIL QUESTIONS addressed to the Minister of State at the Department of Health (Ms. Shortall) 18/09/2012 It is not my intention to introduce supervised injection sites for heroin users. Rather my focus is on ensuring that there is an increased emphasis on providing the opportunities for people to move on from illicit drug use, through drug treatment and rehabilitation, to a drug-free life where that is achievable. A 2012 report from the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) indicates that heroin-assisted treatment is made available only in a small number of European countries. While the report found some evidence that this treatment can be effective for a small minority of entrenched opioid users, the EMCDDA made clear that it was reporting only, rather than advocating the provision of such services.
  • 27. So the evidence …… Proving safer injecting facilities should be viewed as a treatment option to provide the opportunities for people to move on from illicit drug use, through drug treatment and rehabilitation, to a drug-free life where that is achievable.
  • 28. All the pieces to the jig saw fit ……
  • 30. Thanks for listening Tim Bingham Email tim@inef.ie Website www.inef.ie